CD69 and B-cell chronic lymphocytic leukemia: In CLL, CD69 has been reported to be an independent prognostic marker that significantly correlates with poor clinical and biological prognostic factors such as the number of treatment lines, the mutational status of the IGHV genes, and the expression of CD38, ZAP-70 and CD49d [42, 43].